封面
市場調查報告書
商品編碼
1373832

全球獸用抗生劑和抗菌藥物市場 - 市場規模、佔有率、成長分析:按類型、按應用分類 - 產業預測(2023-2030)

Global Animal Antibiotics and Antimicrobials Market Size, Share, Growth Analysis, By Type(Penicillins, Tetracyclines), By Application(Veterinary Hospitals & Clinics, Veterinary Pharmacies) - Industry Forecast 2023-2030

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2021年全球獸用抗生劑和抗菌劑市場規模為43.2億美元,2022年為44.7億美元。預計該市場在預測期(2023-2030年)將以3.5%的年複合成長率成長,到2030年將達到58.9億美元。

全球獸用抗生劑和抗菌藥物市場是獸藥產業的重要組成部分,旨在促進動物健康和福利。全球獸用抗生劑和抗菌劑市場的主要促進因素之一是對動物性蛋白質的需求不斷成長。隨著世界人口的成長和可支配所得的增加,肉、乳和蛋的消費量顯著增加。因此,畜牧業生產不斷擴大,對預防和治療動物感染疾病的抗生素和抗菌藥物的需求增加。市場成長的另一個因素是動物疾病的日益普及。呼吸道感染疾病、胃腸道感染疾病和乳腺炎等感染疾病對動物健康和生產力構成重大威脅。抗生素和抗菌劑在控制和管理這些疾病方面發揮重要作用,刺激了市場需求。此外,人們越來越關注動物福利和減少動物到人類的疾病傳播。抗生素和抗菌藥物對於維持動物健康和福利以及確保最佳生長和生產力至關重要。

禽流感、口蹄疫、豬瘟等動物感染疾病的爆發凸顯了使用抗生素和抗菌藥物來控制和預防疾病傳播的必要性。與疾病爆發相關的潛在經濟損失正在推動對這些產品的需求,特別是在此類疾病流行率較高的地區。這項需求是由保護牲畜健康和維持牲畜生產力的需要所驅動的。

消費者偏好以及食品安全和永續性意識的增強正在增加對不含抗生素的動物產品的需求。消費行為的這些變化促使生產者採用無抗生素生產系統,對獸用抗生素和抗菌藥物的需求產生負面影響。生產者正在透過探索動物疾病預防和促進生長的替代方法來滿足消費者的期望並符合市場趨勢,重點是永續性和減少抗生素的使用。我正在努力。

本報告研究了全球獸用抗生劑和抗菌藥物市場,提供了市場概況,包括按類型、應用、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

母市場分析

市場規模

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務

關鍵市場洞察

  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 趨勢分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度

市場動態及展望

  • 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
  • 法規狀況
  • 波特的分析

全球獸用抗生劑和抗菌劑市場(按類型)

  • 市場概況
  • 青黴素
  • 四環素類
  • 磺醯胺
  • 大環內酯系列
  • Aminoglycosides
  • 氟喹諾酮類及其他

全球獸用抗生劑和抗菌劑市場(按應用)

  • 市場概況
  • 動物醫院、診所
  • 動物藥房
  • 網路藥房

全球獸用抗生劑和抗菌劑市場(按地區)

  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

競爭形勢

  • 主要企業簡介
    • Zoetis Inc.
    • Merck Animal Health
    • Elanco Animal Health
    • Boehringer Ingelheim Animal Health
    • Ceva Sante Animale
    • Vetoquinol SA
    • Bayer Animal Health
    • Virbac
    • Dechra Pharmaceuticals
    • Norbrook Laboratories Ltd.
    • Huvepharma
    • Phibro Animal Health Corporation
    • China Animal Husbandry Co., Ltd.
    • Hester Biosciences Limited
    • Indian Immunologicals Ltd.
    • Hipra
    • Bimeda Holdings Plc
    • Kyoritsu Seiyaku Corporation
    • Vetoquinol
    • Ouro Fino Saude Animal
簡介目錄
Product Code: SQMIG35A2329

Global Animal Antibiotics and Antimicrobials Market size was valued at USD 4.32 billion in 2021 and is poised to grow from USD 4.47 billion in 2022 to USD 5.89 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).

The global animal antibiotics and antimicrobials market is a vital component of the veterinary pharmaceutical industry, aimed at promoting animal health and welfare. One of the primary drivers of the global animal antibiotics and antimicrobials market is the increasing demand for animal protein. With the growing global population and rising disposable incomes, there has been a significant rise in the consumption of meat, milk, and eggs. This has led to the expansion of livestock production, thereby driving the need for antibiotics and antimicrobials to prevent and treat infectious diseases in animals. Another factor contributing to market growth is the rising prevalence of animal diseases. Infectious diseases, such as respiratory infections, gastrointestinal infections, and mastitis, pose a significant threat to animal health and productivity. Antibiotics and antimicrobials play a crucial role in controlling and managing these diseases, thus fueling the demand in the market. Moreover, there is an increasing focus on animal welfare and the reduction of disease transmission from animals to humans. Antibiotics and antimicrobials are essential in maintaining the health and well-being of animals, ensuring their optimal growth and productivity.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Antibiotics And Antimicrobials Market Segmental Analysis

The global animal antibiotics and antimicrobials market is segmented based on type, application, and region. Based on type, the market can be segmented into Penicillins, Tetracyclines, Sulfonamides, Macrolides, Aminoglycosides, Fluoroquinolones, and Others. Based on application, the market is segmented into Veterinary Hospitals & Clinics, Veterinary Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Animal Antibiotics And Antimicrobials Market Dynamics

Drivers of the Global Animal Antibiotics And Antimicrobials Market

Disease Outbreaks and Epidemics

The occurrence of infectious diseases among animals, such as avian influenza, foot-and-mouth disease, and swine fever, underscores the necessity of using antibiotics and antimicrobials to control and prevent the spread of diseases. The potential economic losses associated with disease outbreaks drive the demand for these products, particularly in regions where the prevalence of such diseases is high. This demand stems from the need to protect animal health and maintain productivity within the livestock industry.

Restraints in the Global Animal Antibiotics And Antimicrobials Market

Consumer Preference for Antibiotic-Free Products

Evolving consumer preferences and a heightened awareness regarding food safety and sustainability have resulted in an increased demand for antibiotic-free animal products. This shift in consumer behaviour has motivated producers to adopt antibiotic-free production systems, which in turn has had a negative impact on the demand for animal antibiotics and antimicrobials. Producers are striving to meet consumer expectations and align with market trends by exploring alternative approaches to disease prevention and growth promotion in animals, with a focus on sustainability and reduced antibiotic usage.

Market Trends for Global Animal Antibiotics And Antimicrobials Key

Growing Emphasis on Antibiotic Alternatives and Responsible Use of Antimicrobials. With the rising concerns over antimicrobial resistance (AMR) and its impact on human and animal health, there is a shift towards reducing the use of antibiotics in animal production. This trend is driven by regulatory initiatives, consumer awareness, and a push from industry stakeholders to find effective alternatives that promote animal health while minimising the risk of AMR. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, and vaccines are gaining traction as viable options to maintain animal health and improve performance.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Animal Antibiotics and Antimicrobials Market by Type
    • Market Overview
    • Penicillins
    • Tetracyclines
    • Sulfonamides
    • Macrolides
    • Aminoglycosides
    • Fluoroquinolones and Others.
  • Global Animal Antibiotics and Antimicrobials Market by Application
    • Market Overview
    • Veterinary Hospitals & Clinics
    • Veterinary Pharmacies
    • Online Pharmacies and Others.
  • Global Animal Antibiotics and Antimicrobials Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Zoetis Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck Animal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Elanco Animal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vetoquinol S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer Animal Health (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Dechra Pharmaceuticals (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Norbrook Laboratories Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Huvepharma (Bulgaria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Phibro Animal Health Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • China Animal Husbandry Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hester Biosciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Indian Immunologicals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Hipra (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bimeda Holdings Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Kyoritsu Seiyaku Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Vetoquinol (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ouro Fino Saude Animal (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments